Cala Unveils New Wearable for Hand Tremor Relief

Multiple Waveforms Define the New Standard

San Mateo, California-based Cala has made its kIQ Plus system available across the United States. This new wearable device targets action hand tremors associated with essential tremor and Parkinson’s disease. The launch marks a significant expansion for the company. It allows patients nationwide to access this specific neuromodulation technology. The device represents the next step in their product line.

Health news

Memory Loss May Not Be the First Dementia Warning SignQuiet Nerves 2026 Review: Assessing Claims Behind Nerve Health SupplementBack or spine problems? Mayo Clinic experts explain where to startThe Growing Trend of Caffeinated Nutrition

The kIQ Plus system operates using wearable neuromodulation. It is designed specifically for individuals suffering from involuntary hand movements. Cala states that the U. S. Food and Drug Administration cleared the device earlier this year. This regulatory approval paved the way for its broad market release. The technology aims to provide consistent relief for daily activities.

Why Multiple Stimulation Patterns Matter

A key feature of the kIQ Plus system is its ability to deliver multiple stimulation waveforms. Cala describes it as the first and only wearable to offer this capability. Previous devices typically relied on a single type of electrical pulse. This new approach allows for more personalized treatment options. Patients may find that different waveforms work better for their specific symptoms. This flexibility could improve overall therapeutic outcomes. The company emphasizes that this innovation sets the device apart from competitors. It provides clinicians with greater tools to manage tremor conditions effectively.

The inclusion of various waveforms addresses a common challenge in tremor management. Not every patient responds identically to the same stimulation settings. By offering multiple patterns, the kIQ Plus system adapts to individual needs. This customization is crucial for long-term adherence to therapy. Users can potentially optimize their results without switching devices. The technology remains non-invasive, avoiding the need for surgery. It delivers mild electrical currents to nerves in the wrist. These signals help interrupt the abnormal muscle contractions causing tremors.

Who can use the Cala kIQ Plus system? The device is intended for adults with action hand tremors caused by essential tremor or Parkinson’s disease. It is not designed for other types of movement disorders.

Frequently Asked Questions

Is the device invasive? No, the kIQ Plus system is a wearable device. It does not require surgical implantation or permanent changes to the body.

When did the FDA approve this specific model? The U. S. Food and Drug Administration cleared the kIQ Plus system earlier this year. This approval enabled its nationwide launch.